Bio-Techne Corp.

TECHNASDAQUSD
48.21 USD
0.84 (1.77%)AT CLOSE (11:59 AM EDT)
48.10
0.11 (0.23%)
POST MARKET (AS OF 06:38 PM EDT)
Post Market
AS OF 06:38 PM EDT
48.10
0.11 (0.23%)
🔴Market: CLOSED
Open?$47.30
High?$48.27
Low?$47.11
Prev. Close?$47.37
Volume?2.5M
Avg. Volume?2.9M
VWAP?$47.83
Rel. Volume?0.86x
Bid / Ask
Bid?$47.40 × 200
Ask?$48.80 × 300
Spread?$1.40
Midpoint?$48.10
Valuation & Ratios
Market Cap?7.5B
Shares Out?156.6M
Float?154.8M
Float %?99.0%
P/E Ratio?68.89
P/B Ratio?3.62
EPS?$0.70
Dividend?0.66%
Ex-Dividend?N/A

Bio-Techne Corp. (TECH) trades at $48.21 per share. The stock presents a mixed profile: our models indicate a Buy for underlying fundamentals, while technical indicators flash a Sell. Key drivers include a robust Altman Z-Score, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Furthermore, TECH is currently richly valued, trading at a premium to sector peers across key valuation metrics.

Technical & fundamental data as of May 22, 2026.

News
Profile
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
Employees
3.1K
Market Cap
7.5B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
1989-05-08
Address
614 MCKINLEY PL N E
MINNEAPOLIS, MN 55413
Phone: 612-379-8854
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-2/3)
Medium-Term (Wave)? Neutral(0/3)
Short-Term (Ripple)? Bullish(+2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?
77
Z-Score?
100
Momentum?
75
Short Sent.?
54
Piotroski F-Score?6/9Mixed
Altman Z-Score?11.29Safe
Confidence?68%Moderate
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?8.62%Elevated
Short Interest?13.3M
Days to Cover?6.7
Free Float154.8M
Avg Daily Volume2.0M
Settlement Date2026-04-30
Financial Health
Current Ratio?4.49Strong
Quick Ratio?3.18Strong
Cash Ratio?1.37Strong
Debt/Equity?0.10Low
ValuationRICHLY VALUEDvs 10 peers + S&P 500
Score
50/100
P/E?
Peers
22
S&P
7
68.9PRICEY
P/B?
Peers
30
S&P
48
3.62FAIR
P/S?
Peers
18
S&P
20
6.23FAIR
P/FCF?
Peers
45
S&P
33
28.0FAIR
EV/EBITDA?
Peers
27
S&P
10
29.7HIGH
EV/Sales?
Peers
18
S&P
26
6.23HIGH
Returns & Efficiency
ROE?
Peers
50
S&P
20
5.3%FAIR
ROA?
Peers
44
S&P
39
4.3%FAIR
Cash Flow & Enterprise
FCF?$269.6M
Enterprise Value?$7.5B
Fundamentals ratios updated end of day